| Literature DB >> 22942885 |
Marina B Klein1, Jean-Guy Baril, Marc-André Charron, Claude Fortin, Richard Lalonde, Marie-France Matte, Marc Poliquin, Annie Talbot, Rachel Therrien, Cécile Tremblay, Benoît Trottier, Irina Tsarevsky, Jean-Pierre Villeneuve.
Abstract
The management and treatment of HIV and hepatitis B virus (HBV)-coinfected patients present specific challenges for clinicians. The morbidity and mortality related to these concomitant infections are growing concerns, while the use of antiviral drugs effective against both viruses complicates therapeutic decision making. The present document provides guidelines for physicians regarding care and treatment of patients coinfected with HIV and HBV. Primary prevention of HBV in HIV-positive patients is achieved through appropriate vaccination schedules. Follow-up before treatment of HBV may include liver biopsy, screening for hepatocellular carcinoma and testing for esophageal varicies in cases of cirrhosis. In HBV-infected patients requiring treatment, recommendations regarding initiation, duration and choice of first-line drugs are made. Finally, in the case of resistance, appropriate alternative therapies are necessary.Entities:
Keywords: Antiretroviral therapy; HIV; HIV coinfection; Hepatitis B; Resistance; Vaccination
Year: 2011 PMID: 22942885 PMCID: PMC3200371 DOI: 10.1155/2011/686918
Source DB: PubMed Journal: Can J Infect Dis Med Microbiol ISSN: 1712-9532 Impact factor: 2.471